Ongoing Research and Development Activities
First written in FY2017-Q1. 24 of 29 entries say "Restated". Latest entry: FY2026.
34 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The main research themes and the status of activities for the current consolidated fiscal year are as follows, with total R&D expenses of ¥32.883 million.」
The company continued its existing themes, including young chicken rearing technology, feed cultivation and utilization, and new product development. R&D expenses increased from ¥30.481 million in the previous fiscal year to ¥32.883 million. - FY2025-H1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the interim consolidated accounting period was ¥15.248 million. There were no material changes in the status of the Group’s research and development activities during the interim consolidated accounting period.」
The company continues its R&D activities and disclosed R&D expenses of ¥15.248 million for the current interim consolidated accounting period. It stated that there had been no material changes in the status of these activities. - FY2024-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥15.882 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses research and development expenses of ¥15.882 million for the cumulative period through the second quarter. - FY2024-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥7.813 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses research and development expenses of ¥7.813 million for the current cumulative quarter, together with the absence of material changes in the status of the activities. - FY2023-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥20.169 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses cumulative research and development expenses of ¥20.169 million, together with the absence of material changes in the status of the activities. - FY2023-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥13.293 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥13.293 million for the cumulative period through the second quarter. It states that there were no material changes in the status of the activities. - FY2023-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥6.366 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company discloses the continuation of its research and development activities, research and development expenses of ¥6.366 million, and the absence of material changes in the status of the activities. - FY2022AdvancedAnnual report
「The principal research themes and the status of activities during the current consolidated fiscal year are as follows, and total research and development expenses were ¥24.724 million.」
Research and development expenses were ¥24.724 million, and the company continues to disclose its principal themes, including farming technology for young chickens and other poultry, feed cultivation and utilization, and new product development. - FY2022-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥20.313 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥20.313 million for the cumulative period through the third quarter. It states that there were no material changes in the status of the activities. - FY2022-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥8.071 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥8.071 million for the cumulative period through the first quarter. It states that there were no material changes in the status of the activities. - FY2021RestatedAnnual report
「The principal research themes and the status of activities during the current consolidated fiscal year are as follows, and total research and development expenses were ¥21.248 million.」
The company continues its longstanding principal themes, including farming technology for young chickens and other poultry, feed cultivation and utilization, and new product development, and discloses its research and development expenses. - FY2021-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥17.288 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥17.288 million for the cumulative period through the third quarter. It states that there were no material changes in the status of the activities. - FY2021-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥11.532 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥11.532 million for the cumulative period through the second quarter. It states that there were no material changes in the status of the activities. - FY2021-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥6.641 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥6.641 million for the cumulative period through the first quarter. It states that there were no material changes in the status of the activities. - FY2020RestatedAnnual report
「The principal research themes and the status of activities during the current consolidated fiscal year are as follows, and total research and development expenses were ¥23.570 million.」
The company continues to specifically disclose its longstanding themes, including farming technology for young chickens and other poultry, the cultivation and utilization of feed rice and roughage, and new product development. Research and development expenses declined from ¥28.837 million in the previous fiscal year to ¥23.570 million. - FY2020-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥18.836 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥18.836 million for the cumulative period through the third quarter. It states that there were no material changes in the status of the activities. - FY2020-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥12.253 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥12.253 million for the cumulative period through the second quarter. It states that there were no material changes in the status of the activities. - FY2020-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥7.888 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥7.888 million for the cumulative period through the first quarter. It states that there were no material changes in the status of the activities. - FY2019AdvancedAnnual report
「The principal research themes and the status of activities during the current consolidated fiscal year are as follows, and total research and development expenses were ¥28.837 million.」
The company discloses research and development expenses of ¥28.837 million and describes specific principal themes, including young-chicken farming technology, feed cultivation and utilization, and new product development. - FY2019-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥23.445 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥23.445 million for the cumulative period through the third quarter. It states that there were no material changes in the status of the activities. - FY2019-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥16.106 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥16.106 million for the cumulative period through the second quarter. It states that there were no material changes in the status of the activities. - FY2019-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥9.013 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥9.013 million for the cumulative period through the first quarter. It states that there were no material changes in the status of the activities. - FY2018-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥34.094 million. There were no material changes in the status of the Group’s research and development activities during the third quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥34.094 million for the cumulative period through the third quarter. It states that there were no material changes in the status of the activities. - FY2018-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥23.824 million. There were no material changes in the status of the Group’s research and development activities during the second quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥23.824 million for the cumulative period through the second quarter. It states that there were no material changes in the status of the activities. - FY2018-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥11.551 million. There were no material changes in the status of the Group’s research and development activities during the first quarter of the current consolidated cumulative period.」
The company continues its research and development activities and discloses spending of ¥11.551 million for the cumulative period through the first quarter. It states that there were no material changes in the status of the activities. - FY2017AdvancedAnnual report
「The principal research themes and the status of activities during the current consolidated fiscal year are as follows, and total research and development expenses were ¥30.552 million.」
In addition to continuing its research and development activities, the company reports research and development expenses of ¥30.552 million for the current fiscal year and discloses specific themes, including the gut microbiota of young chickens, colibacillosis and disease prevention, feed rice, self-supplied feed, new products, and lifestyle recommendations focused on health. - FY2017-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the third quarter of the current consolidated cumulative period was ¥22.827 million.」
The company discloses the continuation of research and development activities, with cumulative spending of ¥22.827 million. It also states that there were no material changes in the status of the activities. - FY2017-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the second quarter of the current consolidated cumulative period was ¥15.789 million.」
The company discloses the continuation of research and development activities, together with the amount for the cumulative period through the second quarter. - FY2017-Q1First statedAnnual report
「The amount of research and development activities for the Group as a whole during the first quarter of the current consolidated cumulative period was ¥9.282 million.」
The company discloses the amount spent on research and development activities during the quarter, but does not describe individual research themes or the means of achieving them.